New Immunotherapy Drug Stops Mesothelioma in Half of Patients Tested – Surviving Mesothelioma
Surviving Mesothelioma |
New Immunotherapy Drug Stops Mesothelioma in Half of Patients Tested
Surviving Mesothelioma It is specially made to seek out and enter mesothelioma tumors and other types of cancer cells. Once inside a mesothelioma cell, ONCOS-102 replicates itself, sending a genetic signal that stimulates an anticancer immune response. ONCOS-102 has been … |
